{{Rsnum
|rsid=6500395
|Gene=N4BP1
|Chromosome=16
|position=48587491
|Orientation=plus
|GMAF=0.3756
|Gene_s=N4BP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 38.9 | 50.4
| HCB | 4.4 | 40.9 | 54.7
| JPT | 5.3 | 43.4 | 51.3
| YRI | 44.2 | 40.1 | 15.6
| ASW | 19.3 | 50.9 | 29.8
| CHB | 4.4 | 40.9 | 54.7
| CHD | 5.5 | 37.6 | 56.9
| GIH | 18.8 | 53.5 | 27.7
| LWK | 36.4 | 46.4 | 17.3
| MEX | 32.8 | 46.6 | 20.7
| MKK | 26.3 | 43.6 | 30.1
| TSI | 8.8 | 33.3 | 57.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=6E-7
|OR=2.2000
|ORtxt=None
}}

{{on chip | Illumina Human 1M}}